Generation of 3, 8-substituted 1, 2, 4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)
H Wang, JA Robl, LG Hamann, L Simpkins…
Index: Wang, Haixia; Robl, Jeffrey A.; Hamann, Lawrence G.; Simpkins, Ligaya; Golla, Rajasree; Li, Yi-Xin; Seethala, Ramakrishna; Zvyaga, Tatyana; Gordon, David A.; Li, James J. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 14 p. 4146 - 4149
Full Text: HTML
Citation Number: 16
Abstract
Abstract A series of pyridyl amide/sulfonamide inhibitors of 11β-HSD-1 were modified to incorporate a novel 1, 2, 4-triazolopyridine scaffold. Optimization of substituents at the 3 and 8 position of the TZP core, with a special focus on enhancing metabolic stability, resulted in the identification of compound 38 as a potent and metabolically stable inhibitor of the enzyme.
Related Articles:
[Liscio, Paride; Carotti, Andrea; Asciutti, Stefania; Karlberg, Tobias; Bellocchi, Daniele; Llacuna, Laura; Macchiarulo, Antonio; Aaronson, Stuart A; Schueler, Herwig; Pellicciari, Roberto; Camaioni, Emidio Journal of Medicinal Chemistry, 2014 , vol. 57, # 6 p. 2807 - 2812]
[Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 13 p. 3983 - 3987]
[Bioorganic and Medicinal Chemistry Letters, , vol. 23, # 13 p. 3983 - 3987]